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Durham. A’orrh Carolina 
bolytic therapy. has been shown to improve survival in 
recent clinical trials M-88). Treatment with intracwonary or 
iniiavenous rhmmbdytic agents, however. is limited by 
modest reperfusion r&s ani a significant residual stenosis 
in the infarct-related vessel 13.41. 
Wrcutaneous tmmluminal comnar~ an$ioplasty has heen 
used increasingly in an et% to wxcome the limitations of 
thmmboiytic therapy WS1. Reprfusion ra!es of 84 ID 
ICKC along with an immediate reduction of the underlying 
coronary sknosis, have ken reported in patients treated 
with emergency angiqdarty lalooe or in combimtion with 
xhmmbelytic agentrL but the tong-term outcmne after this 
treatment has not been described. By pmmety reducing the 
residual stenmis and producing a widely patent infarct- 
related awry. an&dasly could reduce the risk of recurrent 
iachemic events and promok zcovery of left ventricular 
function (16). In the Wenem Washington lrial, complete period were eilher randomized to elective coronary angio- 
reperfusion of the infarct-relaled awry with intracomnary plasry or did not have suitable coronary anatomy. 
streptokinare exerted a favorable ir,dependent effect on I Rcprhoslm prwcd. Before December 1985. streptoki- 
year survival (II). even in the absenrc of improvement in IeR oa~e was used to treat each eligible p&et. After that time, 
veniricular function (IS). tissue plasminogen aclivalor (I-PA) was used in patients 
We have previously reported (13) that a strategy of meeting entry criteria for Ihe TAM1 trial and slnptokinase 
womm administmlion of inlravenwi thmmbolylic therapy wes used in the remaining patients. Patient selection criteria 
& referring hospitals followed by air tmnqor&m to &I for treatment with strep~dkinsle were I) continuous ches1 
intewentionsl cenkx for emergency cardiac calhetetization pain consis~eet with myocardial infarction of 56 h dumion 
and sngioplasty is highly effective in establishing early and accompanied by ST segment elevation rl mm In two or 
sustained coronary perfusion. Ihe purpose of the present more contiguous electroardiograpbic @CO) leads or 2) 
study was to describe the survival and cardiac event rales in intermittent (“stuttering”) chest pain of 6 to 24 h duration 
the year efter hospital discharge in a large population of with both pain awl ST segment elevation present on erfivd 
patients with wale myocardial infarction managed wilh this at the medical center. lnuavenous rkeptokinase was admin- 
treatment strategy and 10 specbically examins the outcomes istered as a single b&u of I.5 million onilll in 250 ml of5% 
in high risk patient subgroups. such as patients with cardio- dextrose in watergiven over 30 min as swn es the pfcrump- 
genk shock, who are known to have a pea prognosis when live diiosis of myoeardiai infarction wns ertsblisbcd aed 
treated conservatively. contraindications were excluded. FWientri whose infarct- 
related vessel was not found lo be rq&k?.ed on Ihe first 
arteriwsm underwt immediate ando~lastv woss the 
Methods 
total o&.troctioo. Patients who had io~li~ rep&fusion also 
underwent immediale ~aioolastv unless I) the residual -. . 
Stedy pe~kats. The study group consisted of 342 patients eoronkuy stenosis was s56%. or 2) the coronary s1eeosis 
with wute myocardial iefarclion treated with emergency was unruilable for aogioplaty (because of left main or 
coronary angioplarty at Duke University Medical Center severe dilfw disease. for example) in the presence of brisk 
between March 19&l and August 1966. In the abxnce of aolcrogmde blood (low. Patients with the latter condition 
conlraindicaations, patients were initially kealed wilh e were ~eoemlly referred for coronary bypass &Iii@ during 
thmmbolytic went &eotokinase or tissue plasminown the woe hoaoitaliution. Patients with cardiirdc shock 
activator) and were then lransporkd to the Duke Interv~n- 
tionel Cardiac Catheterization Laboratory for emergency 
eogioplasly. lntraveooos or intraforonery thrombolytic ~her- 
spy was generally administered before angioplesty unless 
any of the following contmiodications were present: I) 
recent history of gasl.minteslinal bleeding, stroke, major 
wgery or trauma (including a pmlonged p&xl of cardio- 
pulmtxwy resuscitation): 2) history of a bleeding disthesis: 
31 proliferative diabetic retinopathy: or 4) severe uncon- 
tmlled hypenendon (diastolic prersure >I?.0 mm fig). I’&- 
dents witA contraindii*wns to iimmbolytic therapy were 
managed wilh angioplasty alone. 
During lb: study pziod. 1,120 plier& with acute myo- 
urdial infarcrion were evaluated ai our medical center. 
Excluded fmm this sludy were 615 priients who were not 
treated wilh :hrombolytic rherapy or coronary angioplasly 
baa!se mey came lo medical altentioo beyond the time sod 
symptom lindts of Lhc stady or were not deemed LO be 
candidates br intervention because of their prcinlarction 
medicai candidon. An additional 1 IO patients mre treated 
with ?treptokinare but were q o, candidates for acute core. 
oe~‘~ axi~olar,v because they did not ative at the medical 
were rw~)( e&led fmm the streptokinarc pm&l. Patients 
~-75 years were considered on M individual b&s according 
10 their medical condition before infarction. 
TAMI trial e/i#bi/hy wirerio for r-P.4 ndmklsrrafion (10 
included I) chest psin of c4 h duration or C6 h duraIion if 
severe on@ng cheat pain was eccompankd by persistent ST 
segment elevation, 2) ST segmeol elevalion ofzz I mm in two 
or more con!iguous ECG leads, 3) age ~75 years. 4) oe 
evidence ofwdiogenic shock, and 5) no history otprevioor 
Q wave infarction in the same vaseolar distribution end oo 
history of previous bypass Brafling. PaIients entering the 
&PA protwol were treeted with a total dotx of I.50 mg over 
6 Lo 8 h with NJ% of the first hour’s dose administered as II 
bolur. Coronary erteriogmphy was perfomwd 90 min after 
I-PA therapy was initiated. Patients found to have total 
occlusion of the infaret-related artery underwent emergency 
aogioplasty. Patienrri with succcssSol reperfurion were ran- 
domized to either emergency angioplasly or elective angio- 
plasly at 7 dlyr unless: I) the residual stenosis was ~50%. or 
2) the coronary stenosis was considered unruitabie for 
angioplasty. Patients who carId nol be reached within the 
tio.c limits of the t-PA emtoad. clderlv uadents or those 
afiier Gin the approprird; lime frame or because their 
_. 
with wdiogenic shock, previous~infarction or prior bypass 
coronary enatomy was not suitable. Finally. 53 of the I I2 gmfling were managed with atreptokinsle and angioplaoly. 
patients enmlkd in the Tbmmbolysis and Angioplarty in 
Myocardia! Infarction (TM(l) I lrial (19) during this lime 
Dell &kcibm. Baseline date on the pertinerd histw, 
physicrd examinetics and laboratory wdics were collecteo 
prosptxlively for ench patient. Results of the imerventional immediate Felling. Siifwant lesions in o?ber vcwls were 
catheterization prwedure and predischaqe diagnmtic carh- approached at a Paler time with eilhn aw@ic@asly or wgery 
etedzation were ako proxpeclively recorded. Fallow-up on an ekcwe basis. 
information regarding cardiac and noncardiac death and Rou+inr mrdinc cam uni, monogement included bedside 
nonfatal myocardial %wtiw as obtained at 6 months, I hemodynamic monitoring for 24 h or until tbc patient’s 
year and annually thsreafcer after the interventional prrce- condition was c~lsidered stab&. Dii&zem. 30 to 90 ml four 
dare. Information was colleckd by a slake cardiologist or a times dzdy. wax started immzdia!eIy after lbc procedure: if a 
revarch associate during a clinic vkit or by a trained relative conlraindkalkm lo dilliaam existed, niedipine ‘as 
inleniewer o~cr Ihz lskphone. Follow-up was MO% com- used. Abeta-adrencr@c bkxkmwa@g+n, wasgirm,oacbicve 
dete. a heart me GO be&min. unless a hemodvramic euntmin- 
When a de&h wa.v reported, details of the event were 
&Caked from tie wending physician for in-hospital deaths 
and fmm family or bystanders for out-of-hospital deaths. 
Thcaedcalhswereclsssiffedbyan independentfourmember 
mortality commitlee as I) sudden, 2) due to recwrent 
myocardial infarclion, 3) olher cardiac, or 4) noncardiac. All 
subsequent hospitalizations were reviewed with the patient’s 
atknding phwicisn 90 that recurrent nonfatal infarction 
could be deleekd. 
Definite nonfatal myocardial infarcrion w rerordrd 
when all lhree of rhefollowing critwia were met: I) a new Q 
wave on the stiard ECG, 2) ekvation of the MB frac!ion 
d creatinc kinwe or reversal of the normal lactic dehydm- 
pnax iw-mzyme I:2 ratio. and 3) symptoms compsliblr 
with acute i&r&n. Rob&k myofardial infaraion was 
dii when two of the three criteria were met. Accuracy 
ofId, method of follow-up hlls kern documented previously 
I;ak&, Caidiienic shock wa defined as sustained 
hvpotetion {syttcdic prerrure of 590 mm HS lssdng for 5 S 
h) sadevidcme dpriphcral hypop+rfiuicm IKillip chars IV) 
(21). Persislca perfusion was considered to be present if :ho 
infax vessel ua cmnpktely p&used al the end of the 
angioplasly prwxdun (lluombolysis in Myocardkl Infarc- 
ii IllMq gmik 2 M 3lf22). The o~tcomc of the coronary 
an~ioplasly prwedurc was classified as I) successful (550% 
residual steno&), 2) pnislmt p=zrtusion with residual rub- 
total stenosis (>5lE% but <INi% stenosis), w 3) unwx~ss- 
Ill with M persisten1 perfusion. Fmcedml monalily was 
defined 89 death occurring in the intervention! cardiac 
cathetefimion laboratory. Mycwdii mfarc, sile was de. 
xri~as~nl~or(STsegnenIekvalion in kads 1, aVL. V, 
to Vd or infwior (ST w&ment ekvation in leads II. 111. 
AVF). 
wt measured. In paticnls with nurltipls k&in tbc i&rct- 
r&ted vessel. au lcriws dlh >a% lumiml diameter nu- 
rowing (YCR dilated if possible. In pal enls with multivessel 
diswe, only [be infarct-related artery was dilated in the 
dication was prent. The betabiosker, &ium channel 
blockmg agent and aotiplatekt tbempy rid, asen and 
dipyridamole were continued throttgbout the ~~~i~~~~. 
After rhr procedure. ECG monitoring w’as conlinued for 
72 to $6 h and consrant rorwillawe was maintained far siges 
or rymproms of recurrent ischtmia. When there was any 
clinical evidence ruggerting reatcnosis or reocclusion. pa- 
lienls underwent emeraency reseat angio$rauby to waltfate 
the 1ranrl&nalreperfwia;ca,he,er fAdvaraedCardic,vas. 
cukr Svstema). a4.5F m&e vafusion rlmlinsrkvkc lbal 
ree%&shcs disial c&nary L&xl Raw until &mary by- 
fnss surgery can bc performed 123). 
DO interval bypass s”r@eiy were asked IO ulrder@ a q=?al 
cardiac caheteriraiion. Four patiinls with mediiai cwlrain~ 
dicadonr were excluded from lbc follow-up sludy. in ens 
case each h+Eax~ix of severe rznal failure, renal f&we and 
adult rcrpimmry distress syndrome, hepain-associated 
B&at&w CkmMusr. The median we of the 342 study 
patients was 58 yca~ trangc 23 to 8.5). id 81% werr: men 
Wable I). There wps P G&t prcdominenee of inferior wall 
i&r&v. Thirty prcentd. ihe pntienh bed on or more 
reriau9 camdications of acute infarction before artiviog in 
the Interve&nal Labaratoty; this group included 43.pa. 
tients (13%) with cantiinh shock. Patients were started a 
tbmmbotytii ~hcrapy ai a median interval of 3 h after the 
onset of pain. Seventeen percent of patients received t-PA 
and 78% received streptokinase. The remdittin9 5% under- 
went angiap&y without p&w thmmbolylic therapy be- 
cause of mn1raindiitionr to this ttwtttw 
agent. calciu~cbsnnel btocktng~nt, asPbin.bipyrtdam& em&t cmwwy by&r wrgery tier inw?ion of a repev 
tf’ersantincl and sublinpual nitmglycerin. and these mcdica- 
lions were continued for 6 months. The patient’s pemonal 
physician W,E advised to refer the patient for pmmp( mewI- 
u&ion with repeat angicgaphy if ixhemic symptoms re- 
‘F& 2. Ba3eIL. AngioQptdc cbardcted”t*s in u* Putt 
curred All surviving patients with inilially sttcarrfttl cola 
lduc~~blcd ytlry 
nv; angioplasty were asked to return for an outpatient 
uD IM tum1 
t.CX 
calheterirarion after 6 months of Follnv+up. After this point. 
treatment with calcium chznncl bkxkcrr and Pcrssntine WBS 
~nenllv discontinued if the site of coronary anaiadastv 
fusion catheter. The remaining patients in whom angioplasty 
was unsuccessftd (6% of tbe lotal study groupl had no 
further evidence of viaMe myocardium at the conclusion of 
the ptwxdure (as judged by persistent ST segment skvation 
sod pahO and were transferred to the crrdiac care unit for 
nwtine postinfw:ion care. 
EZ@ht m&we. The pmcedwai mortatiry rate was 
IX6 and bc tocal in-ha&at mortality rate was II%. 
Comnary bypass stt~ry during the initial hospitalizrdioc 
was petfattted emergently for failed mtgiqdascy in 4% snd 
electively far other disease not amenable to angioplasty in 
65b. One of the 13 pienls whb ccderwent cmqatcy 
surlny died periapratively; rherc were no deaths in the 
patients @cated with elective byps turqety. Nine percent 
of patients tJtKktwenl repeat coronwy xl&pl&sty before 
dixharge ior n~ture~~l occlusion or early rester&s on 
loiiow-up whar$e attetiqtqhy. There ICR 304 hor- 
pital survivon (BY%). Gf the 248 patisntr who had success6d 
repzfuicm. no interval bypass surgery and no medical 
caniraindicationr. 223 (9v-m undelNvcnt repeat cardi calh- 
etchdim before discharge. Ameag these patients. 206 
(9%) were found to have a patent infarct-related vessel. 
Fbnr 1. Oix yeu w-&at Is&l Hasir) and I war infarction-fre: 
NrviY8l (dnw the, after emergcl?cy comaary angioptarty for 
acme myoati illfwcrirm. 
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plas,y and P closed infarct vessel (TIMI grade 0 or It on the had a low r&c of cardiac denth and nonfatal reinfarctian 
initist coroaz~, za$V_~rn. l._r Ct wirr mutrirartsbk analysis during Ihe IS, year after hospital diwharge. Although a 
showed lhst only ca&+r &ck. greater ye. lower number of repmts (5) have described the in-hospit& ad late 
ejection frzc,iun. female gender and a closed Infzrc!-related mortality after thmmbotytic therapy of acute infaruian. 
vessel v:ae inde,a,dcntlv medictive of the risk of subse- there have been M) wevious rewwts of lowterm outcome in 
qucn, wdiovascblar deaih.’ 
Lslr ~t&ame ,a &@ &b ClinM abgospr In-hospital 
monati,~ was incrcascd in several of the clinkat subgroups 
delined using the five independent predicton of long-term 
survival. hut in all cases 1be hospiti wvivon had a very 
Ion I vea- monality raw. The rate of survival to hospital 
discharge 101 the 43 palienrr with cardicwnic shock before 
interventional catheterization was 56%. whereas 93% of 
ua,ien,s without cardiopentc rhcck survived their horoimt- 
&ion. The cumulative t year survival ra,e for tde 43 ,hei;infarction. 
_.. _. . 
b.aticn:s with shock hfore anetcmlastv was 53%. and the I 9(alr walntia. The watients in this trial reoresetd a 
a large population’of patient; with myo&dial infarction 
treated with emer6.wcy angiap::u,y. Recently, several trials 
of invaummary ntreptokinase (17). intravenous streptoki- 
we G9.30) and cambimd intracoronary and intravenous 
streptokinasc (31). rttch with limited nperfttsion rates. have 
been reported. One important differace belween our study 
and previous work, bowever, is IhaI alma, all patients in 
this study undewent a succss~ful mechanical revaxulariza- 
tion uocedun ~andwlastv or rurpervt in the em-Iv phase of 
years hid a 75% harp&t survival rate ‘and a 73% I :ycar 
&a, infarction~frec survival taie Las also 53%. In cmttrast. 
survtval rate. Prermgioplaaty ejection hsction. available in 
the patiems without shock had a I year cumulative survival 
313 p,i:z:i :92%). was also an important prognostic factor. 
The 90 pa,ien,s with a,, ejcciion fmctian c4Ci% had a 
ore of 92% and a I year infarction-free survival rate of&B%. 
bspiital survival ra,c of 81% and a t year survival rme d 
77%. compare;! ui,b 9-f and 92%. rerpcetively. for the 223 
patiemr wilh a,, ejection fraction ~40%. Women uerc at 
The mDnali,y mtes increaxd with age: 55 ps,ien,s qed a45 
increased risk compared with men: at ha&d discharge, 
92% of men and 75% &women were alive. and by I year the 
years had no mortality during the horpilaliration or duty 
rates wcrc 69 and 75%. rcspctively. Patients with a closed 
infact-related verscl on the firs, c~owiry a&m had an 
the Is, war of follow-LID. whereas 69 ,aisnts and 265 
of the pqulation was >ti years oi ag ard 7% w&e >70 
bmad &t&m ofrurc m&rdial infatdort, but~wrstudy 
years. Most prwious interventianal catheteriaii studiis 
have excluded paticota >70 or 75 years (4,6,22.29). The 
was skewed by a gtwtcr than ttormal prevPlcnce of hi&r 
hi&r rat of cardttidc shock and other major comp&a- 
,tmw in MIT population cnmpared with that in ocher wdies 
risk patients. Thirty paw,, of our patients had a potentially 
(4.7.29) may well r&c, a referral bt created by ,be 
av&bility of P regimml systeln of emergency heliiopler 
life.threatening electrical or meehanicat comptkation of 
tMsportatiGl, (32). 
thdr infarction before arrival in the intervenlionat cardiac 
catiwterization labaa,orv (Table II. Twentv.thm ~crcmt 
Alllmugh some cf our study paticms wcrc ,rca,cd with 
strcpt&inase and otben with I-PA. ,IK common feature cd 
their thcrw~ wa tbc use dememencv car&c cathetcrtza- 
855: hcrpi,al wrvivti and M 83% I year suw~~. compared tiw and &ioplasty. At the Ii& & the Ant coronary 
with 95 and 93%. respectively. for patients rvith a patent a&want. men than hatf of the patients Itad oat ye, 
infarct-related vrsscl on the tint an&gram. achieved repmfitsion. AtIer angk&sly or ragioplssty with 
771~ mortalir~ rnw~nrpatienrs increastd with rhe number twmtiximt ctithctcr inxrtimt and surgery, a persistent per- 
of sdwrsr indep-p-ldenr prognosric focrors presenr (radii furion me of 91% I= achieved. 
ftcnk shock, greater age. low ejection fraction. female gen- 
dert. The 70 padenrs GO%t wilh ,wo or more &me 
wb?aQw eDlame. llx po,en,ial of angtqziasty to pre- 
vcn( recurrent irchemic events is undcrscorcd by the reduc- 
pm6matic factors had a hospital survival rate of&% and a 
dth no adverse prognartic factors Imen. a&<65 years, no 
cardiogenic shock and ejection fraction 24C%l had a 96% 
I yea! survival mte of6lR. The 101 patients with only O,K 
ab drurvival10 hospiral discbugc and a I ycarcumuls,ivc 
wrziral rae c$%Z. 
adverse prognostic factor had a hospital survival rate of %% 
and il I year survival rate of 93%. The 142 patients (42%) 
The major tinding of our sludy was that pients ,rea,ed 
with an awes+e regimen of corowy ,hrombolysis and 
cmertwcy an&plas,y during acu,e myocardiil infaxtion 
ptknts treated ailh nrcgokinax and cnqecne~ cornnary 
tion of the ucderlybag residual stenosis to G&z in 8296 of 
an~rtsty, the Cbaspital conclusion rate wa 7% and the 
our patients. Similar pmcedunl results of enagency CMD 
restewxis rate was 12%. Previous repons have indicared 
that compkte rcocclusien mtci of 5 10 15% can be expected 
nary an&pJruty have been rqmrtcd by other investi@orj 
in the host&t aficr wccessfid emergency angiop&,y for 
acute mywrdii infarction (13). Hiir rates of early ROE- 
in mtalkr xries 03.34). However. it! B recent lutte series of 
clusicm 12010 30%) have been rcpwtcd (35.36) in most series 
of padents reccivtn6 intravcnws or intracorcmary thmm- 
botytic therapy done. A, the time ofhos~tal dischars. 94% 
of surviving patiems in mugoup had a patent i&x,-r&&d 
artety or a bypass gmit to the invdvd >‘essnl. Thn high rate subsequent Ion@-term outcome. Vetowet et al. 01) retxxted 
of sustained ptfwion reflects an aggewive strategy of thi*t monatity with an average follow-up ofalmost 1 year was 
in ho:pital monitoring in dhick recwrent ischemic eventl~ 45% when infarct-r&ted Bessel patency war rhici-ed 
were rapidly detected and treated with repeat anioplasty or compared with 25% when thmmbolysisfaiied. OfJhpstlents 
byoass wwrv. treated with emeraetw corottav L 84,“. oidv I dent 
s&&k patients with cardiogetdc shack (37). 
-‘The in-hospital course of our patients wa characterized 
by a significant mortality among certain kigh nsk patients. 
such zu those with evidence of cardiogenic shock before 
initiatiw of therapy. The mortality rate in our patients with 
cardiogenic shock, however, although auhstanti~iy higher 
EMdkLge Mow-ttp. A striking lindiog in our study 
than that for the remainiog patients in GUT study. is noably 
lower lhan the 60 to EO% in-horipid mortality rate reported 
was lhe very low monalily rites observed after hospital 
for psticms with cwdiogenic shock maoaged without inter- 
ventional therapy or with intraaortic balloon pumping only 
dirbatgc. This finding suggests that 811 aggressive approach 
(21.37). Part of this diaerence may derive from the fact thrt 
certain high risk anatomic subsets of patients (such as those 
to dv t’evwxlatization mav alter the natural histow of 
with l&l main coronary artery disease or severe diise three 
vessel disease) ore often not considered candidates for acate 
coronary aogioplasly if they have undergone successful 
coronary rqxrfosion with thmmbolytis therapy. It also 
seems likely, bawever, that acute coronary rmgioplasty is 
nxmosible for simdlicant reduction in the monalitv rate of 
demonstrated that &Lots with brisk rep&&km af the 
infarct-related artery afterthmmbdysis bed a m&x s~wival 
benefit at I year compared wilh patients with partial repr- 
Fusion or failure of throotLwlytic therapy. Thin study also 
developed a logistic regersion m&e! !o predict I yeat 
otortality based cat ej-ectioo Moo, i&trction Iaceticm and 
therspy received (strcptokin.xze or pl~ebo). With this 
model. :he expected I year manality rate in our study 
silbgroup of patients rho were 975 years and who dii not 
have cardioge~ic shnck before 
table with those enrolled in t 
_ 
bnlytic the?* worted to date. did ed aswss cormtary 
attery patency. Despite tk bergs ofpatients with 
pretreatment cardiinic shock in that study canpad with 
oar series. the I yea nwtaliiy rate of patients in the GISSI 
Il7ll) was 17% wth tto treatment. compared with an ob- 
studv who survived the initial bosnitirplizatioa was 7%. Direct 
sewd mortality ra!e of 7% in OUT toal study gnttp. 
The Gruppo It&am, per lo Studio delta Streptochiwi 
nell’lnfarto IGISSI) at&v 17.41). the lamest ~tndv ofthrom- 
saute myocatdial infarction. In studies ~38.40~ of patients 
witb acute myocmdifd infarction before tbe routine use of 
thrombolytic therapy mortality rates between hospital dis- 
charge and 6 months wore apfh’oximately 6 IO 16% with 
attothcr 3 to 4% in the subseqoent 6 months. Haspital 
survivors in the cttmnt study had ao overall mottality rate of 
2% itt the lint 6 moolhs of follow-up and 0% in the 
subsequent 6 months. The trend toward low mortality in 
hospital wn-vivors WBS ptrsettt oat only in Lc overall ~6~tietient 
~a~ttlaliott but also in each hisIt risk subset examined. For 
eximtpk, patients witlt cardiogenic shock before comoary 
attgoplasty h&d an in-hospital tmntality rate of42%, but the 
25 htital survivors had a 6 month mortality rate of446 and 
co&ison of outwmes in the t& otudies is limited by the 
diiTerences in baseline chotecteristics betueen the two pop 
ulations. 
*Ised. Treatment 
pared with movmliasal therapy 
.The lntravettow Stnpcokitwse in 
tioo study (361, for exaot#, recc 
wealed with iott-wermos sltrpIoki 
reinfarctian over the tint 7 mootho compared with 0% in 
thrrewrrenodcathsin¶hisgwpbetween~andIZmwths. p&ems tiondzed to p&xcbo. Previous studies of eRIcT- 
Patients with att ejection fraction <4@% at tlx preaogic- geney angioplily have alsn de 
plasty left ventriculognm had a 19% hospital mortality r&e, in residual stewsis at the time of 
but the 73 hospital survivors had a 6 motttb monalily rate of a lower rate of residual ischemi% 
4% and tto deaths between 6 and I2 momhs. Palienls 165 compard wilh lhox aciiievwl 
yean had ao in-haspiral owality rate d 25% with a poal- done. We believe the redwiott 
discbarge I year mortidity rate of 3%. stcoosis in the iotarct-related 8xt-y ~&ably pccwots for 
Camps_ with prer*u atdies. Several studies the low rate of reio6uction obmed in mu study. 
(5.7.31) have now dacumeutal that the p&y of early I-he proccrs olresrcnosis has rfv? puwJtfa~ji;r fncrt-.zJiKg 
lreatttwd with thmmbolytk tl~erapy reduces Ibe mortality the rate ofrcrurrcnf ischcmio and itfarctiat over the cowse 
obcaitted with conventiod ear:. Only the Ptudy by Vemteer ofpffow-vp. i&a illlm a sttbset of these ptknts atOItr 
(31) et al. and Ihe We*:em Washington trial (4). however. hstitotion indiie that the panem of resten 
bwe evaluated the relation be wecn aog@mpbiially docu- in patients with acute infarctLao from that of 
mated infarct artery patency immediately after therapy and uttdergo elective w&pIasty. In patieets with acute bdarc- 
lion who receive cmeqency nngioplaty. there is a relatively 
hi@h io-hospilal reslenosi%~reocclusion rate compared with 
Ihal of pa:icnrs with elccwe angioplasty. In Ihe first 6 
nmnrhs aher hospital discharge. however. restenosis rates in 
the paricnts with acute infarction are signifGvdly lower (43). 
This finding and the resulls of the current study provide 
sI.wng suppon for the concept that. using an aggressive 
repmfusion straegy. persistent patencyofthe infarct-related 
vessel can be maintained over the long lerm in the vast 
majority of patients with acute infarction with an initially 
successful angioplasty. 
Lbo&a&xts o(sImij. A sipeilicant limilalion ofrhis study 
is the lack of a concurrenl. randomly selected ccmtml group. 
Our ~oal in both the rlreplokinase plus angioplasty and the 
I-PA plus angioplasty proloals was to develop a strategy 
pro? iding the highest possible rates of early and persistent 
infarcr-rrlaled vcsxl DBIFIK‘Y bv invertinatineevolvine com- 
binalions of phnrma&logic &.e& and mechanical mdhods. 
AccordingI?. we cannot exclude the poasibilily that the low 
fates of mortality and recuren! infarction observed in our 
palienfe was produced by some selection bias or occurred by 
chance The higher rales of such events in previous studier 
of Irad;tior:al therapy. including our own. provide supporl 
for the hvmlhesis that Ihe resulls vccuned becaac of 
thenpanic benefit. Additional suppon coow from the 
consistency of the relation between infarcl-related vessel 
parcncy and subsequent survival in other wdies. The haz- 
ads of historic cordmls and inferential reasoning regarding 
therapanic efficac) are well recognized. Although the 
pmved survival benefit ol ~realment with thrombolvtic tber- 
apy in recent clinical trials may preclude the use df control 
pwps managed with tnditional conservative therapy. on- 
going randomized lrials are currently in progress to aswr 
funhcr the role and Liming of coronary an$oplasty in pa- 
tienlr treated initially wilh thrombolylic therapy. Vigilant 
moniioiing for recurrent ischcmia both in the hospital and 
after discharge with the liberal use of additional revascular- 
ization procedure5 ma) partially accoont ior this outcmr~. 
The routine use or addi:ional measures. such ss beta- 
adrcnergic blocking therapy and routine an&graphic reex- 
amination 6 months after the initial procedure. may also 
have conbiboted 10 the low eve”, ra,e~ ohserved. 
Cwl&. We have demonstrated Ihat early adminis- 
tralion of thrombolyclc therapy in acole myocardial infarc- 
tion. followed as won as possible by emergency angio&sly 
and. *hen necrrsxy. emergency surgery. is fe~iblc and is 
associated with lw long-term monalily and reinfarction 
raille~ Infect-related vessel patency without surgery can be 
establ!\hed in z+l% clPaients. These results are carwasted 
nilh available rsdies using thrombolytic therapy alonc. 
which have shown subsmodally lower reperfusion rater and 
higher r&es of reinbction. Fulure stud& compai~ repcr- 
fiisioo s!ratc#es must ronsider long-term .~!comes because 
Ik true impact of any in!erverdional therapy will be evident 
only atIer its effect on late survival and cardiac event ruler is 
detcnincd. 
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